In Vitro Dissolution & Comparative Studies
Pharmaceutical product release testing and comparative dissolution studies performed according to international regulatory standards to support product development and regulatory submission.
Study Purpose
1
Formulation Testing
2
Dissolution Analysis
3
Product Comparison
4
Regulatory Submission
Testing Scope
Dissolution Testing
Evaluation of drug release characteristics under controlled testing conditions.
Comparative Studies
Direct comparison between pharmaceutical formulations.
Biowaiver Support
Studies supporting regulatory biowaiver applications.
Formulation Evaluation
Performance assessment prior to clinical studies.
Testing conditions, dissolution specifications, and acceptance criteria are established according to internationally recognized regulatory frameworks including USP, FDA, and Biopharmaceutics Classification System guidelines to ensure scientifically valid and regulatory-compliant results.
Laboratory Process
Validated laboratory procedures and controlled testing environments ensure consistent, accurate, and reproducible analytical results throughout every study.
✓ Validated analytical methods
✓ Controlled testing procedures
✓ Accurate formulation comparison
✓ Reliable reproducible results
Application Areas
Pharmaceutical formulations are evaluated to support product development decisions by assessing release characteristics and comparative performance during formulation optimization.
Scientifically validated study data is generated to support regulatory documentation requirements and submission processes in accordance with international pharmaceutical standards.
Comparative in vitro testing provides essential biowaiver assessment data used to support regulatory approval pathways and equivalence evaluation between pharmaceutical products.